| Year |
Citation |
Score |
| 2022 |
Mohr ALA, Logan BK, Fogarty MF, Krotulski AJ, Papsun DM, Kacinko SL, Huestis MA, Ropero-Miller JD. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review. Journal of Analytical Toxicology. PMID 35445267 DOI: 10.1093/jat/bkac023 |
0.691 |
|
| 2019 |
Desrosiers NA, Huestis MA. Oral Fluid Drug Testing: Analytical Approaches, Issues and Interpretation of Results. Journal of Analytical Toxicology. PMID 31263897 DOI: 10.1093/jat/bkz048 |
0.309 |
|
| 2017 |
Carlier J, Diao X, Wohlfarth A, Scheidweiler K, Huestis MA.
Metabolite Profiling of ADB-FUBINACA, A New Synthetic Cannabinoid. Current Neuropharmacology. 15: 682-691. PMID 29403341 DOI: 10.2174/1570159X15666161108123419 |
0.357 |
|
| 2017 |
Bouhlal S, Ellefsen KN, Sheskier MB, Singley E, Pirard S, Gorelick DA, Huestis MA, Leggio L. Acute effects of intravenous cocaine administration on serum concentrations of ghrelin, amylin, glucagon-like peptide-1, insulin, leptin and peptide YY and relationships with cardiorespiratory and subjective responses. Drug and Alcohol Dependence. 180: 68-75. PMID 28881319 DOI: 10.1016/J.Drugalcdep.2017.07.033 |
0.303 |
|
| 2017 |
Logan BK, Mohr ALA, Friscia M, Krotulski AJ, Papsun DM, Kacinko SL, Ropero-Miller JD, Huestis MA. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review. Journal of Analytical Toxicology. 1-38. PMID 28459969 DOI: 10.1093/Jat/Bkx031 |
0.731 |
|
| 2017 |
Abulseoud OA, Zuccoli ML, Zhang L, Barnes A, Huestis MA, Lin DT. The acute effect of cannabis on plasma, liver and brain ammonia dynamics, a translational study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 28456476 DOI: 10.1016/J.Euroneuro.2017.03.006 |
0.349 |
|
| 2017 |
Lee MR, Scheidweiler KB, Diao XX, Akhlaghi F, Cummins A, Huestis MA, Leggio L, Averbeck BB. Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay. Molecular Psychiatry. PMID 28289281 DOI: 10.1038/Mp.2017.27 |
0.322 |
|
| 2017 |
Diao X, Carlier J, Zhu M, Pang S, Kronstrand R, Scheidweiler KB, Huestis MA. In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201). Forensic Toxicology. 35: 20-32. PMID 28286577 DOI: 10.1007/S11419-016-0326-9 |
0.313 |
|
| 2017 |
Huestis MA, Tyndale RF. Designer Drugs 2.0. Clinical Pharmacology and Therapeutics. 101: 152-157. PMID 28084644 DOI: 10.1002/Cpt.575 |
0.323 |
|
| 2016 |
Wiegand SL, Swortwood MJ, Huestis MA, Thorp J, Jones HE, Vora NL. Naloxone and Metabolites Quantification in Cord Blood of Prenatally Exposed Newborns and Correlations with Maternal Concentrations. Ajp Reports. 6: e385-e390. PMID 27896019 DOI: 10.1055/S-0036-1593993 |
0.337 |
|
| 2016 |
Baumann MH, Bukhari MO, Lehner KR, Anizan S, Rice KC, Concheiro M, Huestis MA. Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs. Current Topics in Behavioral Neurosciences. PMID 27830575 DOI: 10.1007/7854_2016_53 |
0.352 |
|
| 2016 |
Elmore J, Dillon-Carter O, Partilla J, Ellefsen KN, Concheiro M, Suzuki M, Rice KC, Huestis MA, Baumann MH. Pharmacokinetic Profiles and Pharmacodynamic Effects for Methylone and its Metabolites in Rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27658484 DOI: 10.1038/Npp.2016.213 |
0.361 |
|
| 2016 |
Swortwood MJ, Newmeyer MN, Abulseoud OA, Scheidweiler KB, Huestis MA. Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration. Drug Testing and Analysis. PMID 27647820 DOI: 10.1002/dta.2092 |
0.308 |
|
| 2016 |
Diao X, Scheidweiler KB, Wohlfarth A, Zhu M, Pang S, Huestis MA. Strategies to distinguish new synthetic cannabinoid FUBIMINA (BIM-2201) intake from its isomer THJ-2201: metabolism of FUBIMINA in human hepatocytes. Forensic Toxicology. 34: 256-267. PMID 27547265 DOI: 10.1007/S11419-016-0312-2 |
0.314 |
|
| 2016 |
Feasel MG, Wohlfarth A, Nilles JM, Pang S, Kristovich RL, Huestis MA. Metabolism of Carfentanil, an Ultra-Potent Opioid, in Human Liver Microsomes and Human Hepatocytes by High-Resolution Mass Spectrometry. The Aaps Journal. PMID 27495118 DOI: 10.1208/S12248-016-9963-5 |
0.319 |
|
| 2016 |
Andersson M, Scheidweiler KB, Sempio C, Barnes AJ, Huestis MA. Simultaneous quantification of 11 cannabinoids and metabolites in human urine by liquid chromatography tandem mass spectrometry using WAX-S tips. Analytical and Bioanalytical Chemistry. PMID 27422645 DOI: 10.1007/S00216-016-9765-8 |
0.392 |
|
| 2016 |
Ellefsen KN, Concheiro M, Huestis MA. Synthetic cathinone pharmacokinetics, analytical methods, and toxicological findings from human performance and postmortem cases. Drug Metabolism Reviews. 1-29. PMID 27249313 DOI: 10.1080/03602532.2016.1188937 |
0.367 |
|
| 2016 |
Scheidweiler KB, Newmeyer MN, Barnes AJ, Huestis MA. Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry. Journal of Chromatography. A. PMID 27236483 DOI: 10.1016/J.Chroma.2016.05.024 |
0.399 |
|
| 2016 |
Carlier J, Scheidweiler KB, Wohlfarth A, Salmeron BD, Baumann MH, Huestis MA. Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometry. Journal of Chromatography. A. PMID 27208987 DOI: 10.1016/J.Chroma.2016.05.020 |
0.358 |
|
| 2016 |
Swortwood MJ, Ellefsen KN, Wohlfarth A, Diao X, Concheiro-Guisan M, Kronstrand R, Huestis MA. First metabolic profile of PV8, a novel synthetic cathinone, in human hepatocytes and urine by high-resolution mass spectrometry. Analytical and Bioanalytical Chemistry. PMID 27185540 DOI: 10.1007/S00216-016-9599-4 |
0.355 |
|
| 2016 |
Ellefsen KN, Concheiro M, Pirard S, Gorelick DA, Huestis MA. Pharmacodynamic effects and relationships to plasma and oral fluid pharmacokinetics after intravenous cocaine administration. Drug and Alcohol Dependence. PMID 27114201 DOI: 10.1016/J.Drugalcdep.2016.04.004 |
0.354 |
|
| 2016 |
Hartman RL, Richman JE, Hayes CE, Huestis MA. Drug Recognition Expert (DRE) examination characteristics of cannabis impairment. Accident; Analysis and Prevention. 92: 219-229. PMID 27107471 DOI: 10.1016/J.Aap.2016.04.012 |
0.319 |
|
| 2016 |
Swortwood MJ, Scheidweiler KB, Barnes AJ, Jansson LM, Huestis MA. Simultaneous quantification of buprenorphine, naloxone and phase I and II metabolites in plasma and breastmilk by liquid chromatography-tandem mass spectrometry. Journal of Chromatography. A. PMID 27083254 DOI: 10.1016/J.Chroma.2016.03.076 |
0.37 |
|
| 2016 |
Ellefsen KN, Concheiro M, Pirard S, Gorelick DA, Huestis MA. Cocaine and benzoylecgonine oral fluid on-site screening and confirmation. Drug Testing and Analysis. PMID 26968560 DOI: 10.1002/Dta.1966 |
0.326 |
|
| 2016 |
Hartman RL, Brown TL, Milavetz G, Spurgin A, Pierce RS, Gorelick DA, Gaffney G, Huestis MA. Cannabis effects on driving longitudinal control with and without alcohol. Journal of Applied Toxicology : Jat. PMID 26889769 DOI: 10.1002/Jat.3295 |
0.303 |
|
| 2016 |
Ellefsen KN, Concheiro M, Pirard S, Gorelick DA, Huestis MA. Oral fluid cocaine and benzoylecgonine concentrations following controlled intravenous cocaine administration. Forensic Science International. 260: 95-101. PMID 26851651 DOI: 10.1016/J.Forsciint.2016.01.013 |
0.337 |
|
| 2016 |
Hartman RL, Brown TL, Milavetz G, Spurgin A, Gorelick DA, Gaffney GR, Huestis MA. Effect of Blood Collection Time on Measured Δ9-Tetrahydrocannabinol Concentrations: Implications for Driving Interpretation and Drug Policy. Clinical Chemistry. 62: 367-77. PMID 26823611 DOI: 10.1373/Clinchem.2015.248492 |
0.307 |
|
| 2016 |
Diao X, Scheidweiler KB, Wohlfarth A, Pang S, Kronstrand R, Huestis MA. In Vitro and In Vivo Human Metabolism of Synthetic Cannabinoids FDU-PB-22 and FUB-PB-22. The Aaps Journal. PMID 26810398 DOI: 10.1208/S12248-016-9867-4 |
0.304 |
|
| 2016 |
Ellefsen KN, Wohlfarth A, Swortwood MJ, Diao X, Concheiro M, Huestis MA. 4-Methoxy-α-PVP: in silico prediction, metabolic stability, and metabolite identification by human hepatocyte incubation and high-resolution mass spectrometry. Forensic Toxicology. 34: 61-75. PMID 26793277 DOI: 10.1007/S11419-015-0287-4 |
0.322 |
|
| 2016 |
Andås HT, Enger A, Øiestad ÅM, Vindenes V, Christophersen AS, Huestis MA, Øiestad EL. Extended Detection of Amphetamine and Methamphetamine in Oral Fluid. Therapeutic Drug Monitoring. 38: 114-9. PMID 26402425 DOI: 10.1097/Ftd.0000000000000248 |
0.391 |
|
| 2015 |
Diao X, Wohlfarth A, Pang S, Scheidweiler KB, Huestis MA. High-Resolution Mass Spectrometry for Characterizing the Metabolism of Synthetic Cannabinoid THJ-018 and Its 5-Fluoro Analog THJ-2201 after Incubation in Human Hepatocytes. Clinical Chemistry. PMID 26430074 DOI: 10.1373/Clinchem.2015.243535 |
0.372 |
|
| 2015 |
Lee D, Bergamaschi MM, Milman G, Barnes AJ, Queiroz RH, Vandrey R, Huestis MA. Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users. Journal of Analytical Toxicology. 39: 580-7. PMID 26378131 DOI: 10.1093/Jat/Bkv082 |
0.576 |
|
| 2015 |
Wohlfarth A, Scheidweiler KB, Pang S, Zhu M, Castaneto M, Kronstrand R, Huestis MA. Metabolic characterization of AH-7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmation. Drug Testing and Analysis. PMID 26331297 DOI: 10.1002/Dta.1856 |
0.343 |
|
| 2015 |
Ellefsen KN, da Costa JL, Concheiro M, Anizan S, Barnes AJ, Pirard S, Gorelick DA, Huestis MA. Cocaine and metabolite concentrations in DBS and venous blood after controlled intravenous cocaine administration. Bioanalysis. 7: 2041-56. PMID 26327184 DOI: 10.4155/Bio.15.127 |
0.307 |
|
| 2015 |
Huestis MA. Cannabis-impaired driving: a public health and safety concern. Clinical Chemistry. 61: 1223-5. PMID 26283691 DOI: 10.1373/Clinchem.2015.245001 |
0.36 |
|
| 2015 |
Huestis MA. Deterring driving under the influence of cannabis. Addiction (Abingdon, England). 110: 1697-8. PMID 26264558 DOI: 10.1111/Add.13041 |
0.304 |
|
| 2015 |
Hartman RL, Brown TL, Milavetz G, Spurgin A, Gorelick DA, Gaffney G, Huestis MA. Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships. Drug Testing and Analysis. PMID 26257143 DOI: 10.1002/Dta.1839 |
0.349 |
|
| 2015 |
Karschner EL, Swortwood MJ, Hirvonen J, Goodwin RS, Bosker WM, Ramaekers JG, Huestis MA. Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance. Drug Testing and Analysis. PMID 26097154 DOI: 10.1002/Dta.1825 |
0.391 |
|
| 2015 |
Hartman RL, Brown TL, Milavetz G, Spurgin A, Gorelick DA, Gaffney G, Huestis MA. Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol. Clinical Chemistry. 61: 850-69. PMID 26019183 DOI: 10.1373/Clinchem.2015.238287 |
0.312 |
|
| 2015 |
Tanner JA, Novalen M, Jatlow P, Huestis MA, Murphy SE, Kaprio J, Kankaanpää A, Galanti L, Stefan C, George TP, Benowitz NL, Lerman C, Tyndale RF. Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different Analytical Methods and Laboratories: Implications for Clinical Implementation. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26014804 DOI: 10.1158/1055-9965.Epi-14-1381 |
0.325 |
|
| 2015 |
Battal D, Barnes AJ, Castaneto MS, Martin TM, Klette KL, Huestis MA. Urine mescaline screening with a biochip array immunoassay and quantification by gas chromatography-mass spectrometry. Therapeutic Drug Monitoring. PMID 25992796 DOI: 10.1097/Ftd.0000000000000220 |
0.379 |
|
| 2015 |
Concheiro M, Castaneto M, Kronstrand R, Huestis MA. Simultaneous determination of 40 novel psychoactive stimulants in urine by liquid chromatography-high resolution mass spectrometry and library matching. Journal of Chromatography. A. 1397: 32-42. PMID 25931378 DOI: 10.1016/J.Chroma.2015.04.002 |
0.353 |
|
| 2015 |
Castaneto MS, Barnes AJ, Concheiro M, Klette KL, Martin TA, Huestis MA. Biochip array technology immunoassay performance and quantitative confirmation of designer piperazines for urine workplace drug testing. Analytical and Bioanalytical Chemistry. 407: 4639-48. PMID 25903022 DOI: 10.1007/S00216-015-8660-Z |
0.342 |
|
| 2015 |
Castaneto MS, Wohlfarth A, Desrosiers NA, Hartman RL, Gorelick DA, Huestis MA. Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices. Drug Metabolism Reviews. 47: 124-74. PMID 25853390 DOI: 10.3109/03602532.2015.1029635 |
0.363 |
|
| 2015 |
Newmeyer MN, Concheiro M, da Costa JL, Flegel R, Gorelick DA, Huestis MA. Oral fluid with three modes of collection and plasma methamphetamine and amphetamine enantiomer concentrations after controlled intranasal l-methamphetamine administration. Drug Testing and Analysis. PMID 25786659 DOI: 10.1002/Dta.1784 |
0.388 |
|
| 2015 |
Manini AF, Yiannoulos G, Bergamaschi MM, Hernandez S, Olmedo R, Barnes AJ, Winkel G, Sinha R, Jutras-Aswad D, Huestis MA, Hurd YL. Safety and pharmacokinetics of oral cannabidiol when administered concomitantly with intravenous fentanyl in humans. Journal of Addiction Medicine. 9: 204-10. PMID 25748562 DOI: 10.1097/Adm.0000000000000118 |
0.305 |
|
| 2015 |
Desrosiers NA, Ramaekers JG, Chauchard E, Gorelick DA, Huestis MA. Smoked cannabis' psychomotor and neurocognitive effects in occasional and frequent smokers. Journal of Analytical Toxicology. 39: 251-61. PMID 25745105 DOI: 10.1093/Jat/Bkv012 |
0.322 |
|
| 2015 |
Wohlfarth A, Castaneto MS, Zhu M, Pang S, Scheidweiler KB, Kronstrand R, Huestis MA. Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA. The Aaps Journal. 17: 660-77. PMID 25721194 DOI: 10.1208/S12248-015-9721-0 |
0.313 |
|
| 2015 |
Barnes AJ, Spinelli E, Young S, Martin TM, Kleete KL, Huestis MA. Validation of an ELISA Synthetic Cannabinoids Urine Assay. Therapeutic Drug Monitoring. PMID 25706046 DOI: 10.1097/Ftd.0000000000000201 |
0.309 |
|
| 2015 |
Desrosiers NA, Scheidweiler KB, Huestis MA. Quantification of six cannabinoids and metabolites in oral fluid by liquid chromatography-tandem mass spectrometry. Drug Testing and Analysis. 7: 684-94. PMID 25428610 DOI: 10.1002/Dta.1753 |
0.397 |
|
| 2015 |
Concheiro M, Newmeyer MN, da Costa JL, Flegel R, Gorelick DA, Huestis MA. Morphine and codeine in oral fluid after controlled poppy seed administration. Drug Testing and Analysis. 7: 586-91. PMID 25345619 DOI: 10.1002/Dta.1742 |
0.341 |
|
| 2015 |
Wohlfarth A, Scheidweiler KB, Castaneto M, Gandhi AS, Desrosiers NA, Klette KL, Martin TM, Huestis MA. Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens. Clinical Chemistry and Laboratory Medicine : Cclm / Fescc. 53: 423-34. PMID 25263309 DOI: 10.1515/Cclm-2014-0612 |
0.352 |
|
| 2015 |
Castaneto MS, Scheidweiler KB, Gandhi A, Wohlfarth A, Klette KL, Martin TM, Huestis MA. Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens. Drug Testing and Analysis. 7: 483-93. PMID 25231213 DOI: 10.1002/Dta.1709 |
0.386 |
|
| 2015 |
Scheidweiler KB, Jarvis MJ, Huestis MA. Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry. Analytical and Bioanalytical Chemistry. 407: 883-97. PMID 25224637 DOI: 10.1007/S00216-014-8118-8 |
0.355 |
|
| 2015 |
Lee D, Vandrey R, Mendu DR, Murray JA, Barnes AJ, Huestis MA. Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking. Drug Testing and Analysis. 7: 494-501. PMID 25220020 DOI: 10.1002/Dta.1718 |
0.581 |
|
| 2015 |
Spinelli E, Barnes AJ, Young S, Castaneto MS, Martin TM, Klette KL, Huestis MA. Performance characteristics of an ELISA screening assay for urinary synthetic cannabinoids. Drug Testing and Analysis. 7: 467-74. PMID 25167963 DOI: 10.1002/Dta.1702 |
0.344 |
|
| 2015 |
Anizan S, Bergamaschi MM, Barnes AJ, Milman G, Desrosiers N, Lee D, Gorelick DA, Huestis MA. Impact of oral fluid collection device on cannabinoid stability following smoked cannabis. Drug Testing and Analysis. 7: 114-20. PMID 24995604 DOI: 10.1002/Dta.1688 |
0.556 |
|
| 2015 |
Gandhi AS, Wohlfarth A, Zhu M, Pang S, Castaneto M, Scheidweiler KB, Huestis MA. High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes. Drug Testing and Analysis. 7: 187-98. PMID 24827428 DOI: 10.1002/Dta.1662 |
0.32 |
|
| 2015 |
Scheidweiler KB, Himes SK, Desrosiers NA, Huestis MA. In vitro stability of free and glucuronidated cannabinoids in blood and plasma collected in plastic gray-top sodium fluoride tubes following controlled smoked cannabis Forensic Toxicology. DOI: 10.1007/S11419-015-0290-9 |
0.332 |
|
| 2015 |
Castaneto MS, Wohlfarth A, Pang S, Zhu M, Scheidweiler KB, Kronstrand R, Huestis MA. Identification of AB-FUBINACA metabolites in human hepatocytes and urine using high-resolution mass spectrometry Forensic Toxicology. 33: 295-310. DOI: 10.1007/S11419-015-0275-8 |
0.339 |
|
| 2015 |
Hartman RL, Anizan S, Jang M, Brown TL, Yun K, Gorelick DA, Milavetz G, Spurgin A, Gaffney G, Huestis MA. Cannabinoid disposition in oral fluid after controlled vaporizer administration with and without alcohol Forensic Toxicology. DOI: 10.1007/S11419-015-0269-6 |
0.371 |
|
| 2015 |
Newmeyer MN, Concheiro M, da Costa JL, LoDico C, Gorelick DA, Huestis MA. Simultaneous plasma and oral fluid morphine and codeine concentrations after controlled administration of poppy seeds with known opiate content Forensic Toxicology. 33: 235-243. DOI: 10.1007/S11419-015-0266-9 |
0.368 |
|
| 2015 |
Ellefsen KN, Concheiro M, Suzuki M, Rice KC, Elmore JS, Baumann MH, Huestis MA. Quantification of methylone and metabolites in rat and human plasma by liquid chromatography-tandem mass spectrometry Forensic Toxicology. 33: 202-212. DOI: 10.1007/S11419-015-0263-Z |
0.376 |
|
| 2014 |
Kuwabara H, Heishman SJ, Brasic JR, Contoreggi C, Cascella N, Mackowick KM, Taylor R, Rousset O, Willis W, Huestis MA, Concheiro M, Wand G, Wong DF, Volkow ND. Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers. Plos One. 9: e113694. PMID 25493427 DOI: 10.1371/Journal.Pone.0113694 |
0.308 |
|
| 2014 |
Castaneto MS, Desrosiers NA, Ellefsen K, Anizan S, Martin TM, Klette KL, Huestis MA. Method validation of the biochip array technology for synthetic cannabinoids detection in urine. Bioanalysis. 6: 2919-30. PMID 25486237 DOI: 10.4155/Bio.14.150 |
0.313 |
|
| 2014 |
Anizan S, Concheiro M, Lehner KR, Bukhari MO, Suzuki M, Rice KC, Baumann MH, Huestis MA. Linear pharmacokinetics of 3,4-methylenedioxypyrovalerone (MDPV) and its metabolites in the rat: relationship to pharmacodynamic effects. Addiction Biology. PMID 25475011 DOI: 10.1111/Adb.12201 |
0.389 |
|
| 2014 |
Hartman RL, Huestis MA. Re: "trends in alcohol and other drugs detected in fatally injured drivers in the United States, 1999-2010". American Journal of Epidemiology. 180: 862-3. PMID 25245042 DOI: 10.1093/Aje/Kwu251 |
0.382 |
|
| 2014 |
Smith ML, Nichols DC, Underwood P, Fuller Z, Moser MA, Flegel R, Gorelick DA, Newmeyer MN, Concheiro M, Huestis MA. Methamphetamine and amphetamine isomer concentrations in human urine following controlled Vicks VapoInhaler administration. Journal of Analytical Toxicology. 38: 524-7. PMID 25217541 DOI: 10.1093/Jat/Bku077 |
0.367 |
|
| 2014 |
Ellefsen KN, Concheiro M, Beck O, Gorelick DA, Pirard S, Huestis MA. Quantification of cocaine and metabolites in exhaled breath by liquid chromatography-high-resolution mass spectrometry following controlled administration of intravenous cocaine. Analytical and Bioanalytical Chemistry. 406: 6213-23. PMID 25129634 DOI: 10.1007/S00216-014-8051-X |
0.333 |
|
| 2014 |
Newmeyer MN, Concheiro M, Huestis MA. Rapid quantitative chiral amphetamines liquid chromatography-tandem mass spectrometry: method in plasma and oral fluid with a cost-effective chiral derivatizing reagent. Journal of Chromatography. A. 1358: 68-74. PMID 25065924 DOI: 10.1016/J.Chroma.2014.06.096 |
0.38 |
|
| 2014 |
Gandhi AS, Zhu M, Pang S, Wohlfarth A, Scheidweiler KB, Huestis MA. Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS. Bioanalysis. 6: 1471-85. PMID 25046048 DOI: 10.4155/Bio.14.13 |
0.367 |
|
| 2014 |
Wohlfarth A, Pang S, Zhu M, Gandhi AS, Scheidweiler KB, Huestis MA. Metabolism of RCS-8, a synthetic cannabinoid with cyclohexyl structure, in human hepatocytes by high-resolution MS. Bioanalysis. 6: 1187-200. PMID 24946920 DOI: 10.4155/Bio.14.1 |
0.316 |
|
| 2014 |
Smith ML, Nichols DC, Underwood P, Fuller Z, Moser MA, LoDico C, Gorelick DA, Newmeyer MN, Concheiro M, Huestis MA. Morphine and codeine concentrations in human urine following controlled poppy seeds administration of known opiate content. Forensic Science International. 241: 87-90. PMID 24887324 DOI: 10.1016/J.Forsciint.2014.04.042 |
0.359 |
|
| 2014 |
Anizan S, Ellefsen K, Concheiro M, Suzuki M, Rice KC, Baumann MH, Huestis MA. 3,4-Methylenedioxypyrovalerone (MDPV) and metabolites quantification in human and rat plasma by liquid chromatography-high resolution mass spectrometry. Analytica Chimica Acta. 827: 54-63. PMID 24832995 DOI: 10.1016/J.Aca.2014.04.015 |
0.396 |
|
| 2014 |
Desrosiers NA, Milman G, Mendu DR, Lee D, Barnes AJ, Gorelick DA, Huestis MA. Cannabinoids in oral fluid by on-site immunoassay and by GC-MS using two different oral fluid collection devices. Analytical and Bioanalytical Chemistry. 406: 4117-28. PMID 24828976 DOI: 10.1007/S00216-014-7813-9 |
0.59 |
|
| 2014 |
Lee D, Schroeder JR, Karschner EL, Goodwin RS, Hirvonen J, Gorelick DA, Huestis MA. Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 23: 234-42. PMID 24724880 DOI: 10.1111/J.1521-0391.2014.12088.X |
0.551 |
|
| 2014 |
Ellefsen KN, Anizan S, Castaneto MS, Desrosiers NA, Martin TM, Klette KL, Huestis MA. Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology. Drug Testing and Analysis. 6: 728-38. PMID 24659527 DOI: 10.1002/Dta.1633 |
0.346 |
|
| 2014 |
Newmeyer MN, Desrosiers NA, Lee D, Mendu DR, Barnes AJ, Gorelick DA, Huestis MA. Cannabinoid disposition in oral fluid after controlled cannabis smoking in frequent and occasional smokers. Drug Testing and Analysis. 6: 1002-10. PMID 24652685 DOI: 10.1002/Dta.1632 |
0.612 |
|
| 2014 |
Barnes AJ, Scheidweiler KB, Huestis MA. Quantification of 11-nor-9-carboxy-δ9-tetrahydrocannabinol in human oral fluid by gas chromatography-tandem mass spectrometry. Therapeutic Drug Monitoring. 36: 225-33. PMID 24622724 DOI: 10.1097/01.Ftd.0000443071.30662.01 |
0.368 |
|
| 2014 |
Desrosiers NA, Himes SK, Scheidweiler KB, Concheiro-Guisan M, Gorelick DA, Huestis MA. Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis. Clinical Chemistry. 60: 631-43. PMID 24563491 DOI: 10.1373/Clinchem.2013.216507 |
0.359 |
|
| 2014 |
Scheidweiler KB, Huestis MA. Simultaneous quantification of 20 synthetic cannabinoids and 21 metabolites, and semi-quantification of 12 alkyl hydroxy metabolites in human urine by liquid chromatography-tandem mass spectrometry. Journal of Chromatography. A. 1327: 105-17. PMID 24418231 DOI: 10.1016/J.Chroma.2013.12.067 |
0.341 |
|
| 2014 |
Himes SK, Concheiro M, Scheidweiler KB, Huestis MA. Validation of a novel method to identify in utero ethanol exposure: simultaneous meconium extraction of fatty acid ethyl esters, ethyl glucuronide, and ethyl sulfate followed by LC-MS/MS quantification. Analytical and Bioanalytical Chemistry. 406: 1945-55. PMID 24408304 DOI: 10.1007/S00216-013-7600-Z |
0.314 |
|
| 2014 |
Desrosiers NA, Lee D, Scheidweiler KB, Concheiro-Guisan M, Gorelick DA, Huestis MA. In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis. Analytical and Bioanalytical Chemistry. 406: 785-92. PMID 24292435 DOI: 10.1007/S00216-013-7524-7 |
0.548 |
|
| 2014 |
Desrosiers NA, Lee D, Concheiro-Guisan M, Scheidweiler KB, Gorelick DA, Huestis MA. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers? Clinical Chemistry. 60: 361-72. PMID 24185550 DOI: 10.1373/Clinchem.2013.214106 |
0.57 |
|
| 2014 |
Anizan S, Huestis MA. The potential role of oral fluid in antidoping testing. Clinical Chemistry. 60: 307-22. PMID 24153253 DOI: 10.1373/Clinchem.2013.209676 |
0.377 |
|
| 2014 |
Concheiro M, Baumann MH, Scheidweiler KB, Rothman RB, Marrone GF, Huestis MA. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 42: 119-25. PMID 24141857 DOI: 10.1124/Dmd.113.053678 |
0.348 |
|
| 2014 |
Milman G, Bergamaschi MM, Lee D, Mendu DR, Barnes AJ, Vandrey R, Huestis MA. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence Therapeutic Drug Monitoring. 36: 218-224. PMID 24067260 DOI: 10.1097/Ftd.0B013E3182A5C446 |
0.598 |
|
| 2014 |
Lee D, Huestis MA. Current knowledge on cannabinoids in oral fluid. Drug Testing and Analysis. 6: 88-111. PMID 23983217 DOI: 10.1002/Dta.1514 |
0.621 |
|
| 2013 |
Hartman RL, Desrosiers NA, Barnes AJ, Yun K, Scheidweiler KB, Kolbrich-Spargo EA, Gorelick DA, Goodwin RS, Huestis MA. 3,4-Methylenedioxymethamphetamine (MDMA) and metabolites disposition in blood and plasma following controlled oral administration. Analytical and Bioanalytical Chemistry. PMID 24232751 DOI: 10.1007/S00216-013-7468-Y |
0.35 |
|
| 2013 |
Concheiro M, Anizan S, Ellefsen K, Huestis MA. Simultaneous quantification of 28 synthetic cathinones and metabolites in urine by liquid chromatography-high resolution mass spectrometry. Analytical and Bioanalytical Chemistry. 405: 9437-48. PMID 24196122 DOI: 10.1007/S00216-013-7386-Z |
0.335 |
|
| 2013 |
Himes SK, Scheidweiler KB, Beck O, Gorelick DA, Desrosiers NA, Huestis MA. Cannabinoids in exhaled breath following controlled administration of smoked cannabis. Clinical Chemistry. 59: 1780-9. PMID 24046200 DOI: 10.1373/Clinchem.2013.207407 |
0.333 |
|
| 2013 |
Wohlfarth A, Pang S, Zhu M, Gandhi AS, Scheidweiler KB, Liu HF, Huestis MA. First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometry. Clinical Chemistry. 59: 1638-48. PMID 24014837 DOI: 10.1373/Clinchem.2013.209965 |
0.34 |
|
| 2013 |
Anizan S, Milman G, Desrosiers N, Barnes AJ, Gorelick DA, Huestis MA. Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers. Analytical and Bioanalytical Chemistry. 405: 8451-61. PMID 23954944 DOI: 10.1007/S00216-013-7291-5 |
0.377 |
|
| 2013 |
Gorelick DA, Goodwin RS, Schwilke E, Schroeder JR, Schwope DM, Kelly DL, Ortemann-Renon C, Bonnet D, Huestis MA. Around-the-clock oral THC effects on sleep in male chronic daily cannabis smokers. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 22: 510-4. PMID 23952899 DOI: 10.1111/J.1521-0391.2013.12003.X |
0.711 |
|
| 2013 |
Lee D, Vandrey R, Mendu DR, Anizan S, Milman G, Murray JA, Barnes AJ, Huestis MA. Oral fluid cannabinoids in chronic cannabis smokers during oral δ9-tetrahydrocannabinol therapy and smoked cannabis challenge. Clinical Chemistry. 59: 1770-9. PMID 23938457 DOI: 10.1373/Clinchem.2013.207316 |
0.608 |
|
| 2013 |
Gandhi AS, Zhu M, Pang S, Wohlfarth A, Scheidweiler KB, Liu HF, Huestis MA. First characterization of AKB-48 metabolism, a novel synthetic cannabinoid, using human hepatocytes and high-resolution mass spectrometry. The Aaps Journal. 15: 1091-8. PMID 23913126 DOI: 10.1208/S12248-013-9516-0 |
0.371 |
|
| 2013 |
Lee D, Vandrey R, Milman G, Bergamaschi M, Mendu DR, Murray JA, Barnes AJ, Huestis MA. Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration. Analytical and Bioanalytical Chemistry. 405: 7269-79. PMID 23831756 DOI: 10.1007/S00216-013-7159-8 |
0.601 |
|
| 2013 |
Concheiro M, Lee D, Lendoiro E, Huestis MA. Simultaneous quantification of Δ(9)-tetrahydrocannabinol, 11-nor-9-carboxy-tetrahydrocannabinol, cannabidiol and cannabinol in oral fluid by microflow-liquid chromatography-high resolution mass spectrometry. Journal of Chromatography. A. 1297: 123-30. PMID 23726246 DOI: 10.1016/J.Chroma.2013.04.071 |
0.593 |
|
| 2013 |
Scheidweiler KB, Himes SK, Chen X, Liu HF, Huestis MA. 11-Nor-9-carboxy-∆9-tetrahydrocannabinol quantification in human oral fluid by liquid chromatography-tandem mass spectrometry. Analytical and Bioanalytical Chemistry. 405: 6019-27. PMID 23681203 DOI: 10.1007/S00216-013-7027-6 |
0.432 |
|
| 2013 |
Eiden RD, Homish GG, Colder CR, Schuetze P, Gray TR, Huestis MA. Changes in smoking patterns during pregnancy. Substance Use & Misuse. 48: 513-22. PMID 23581507 DOI: 10.3109/10826084.2013.787091 |
0.313 |
|
| 2013 |
Scheidweiler KB, Schwope DM, Karschner EL, Desrosiers NA, Gorelick DA, Huestis MA. In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis. Clinical Chemistry. 59: 1108-17. PMID 23519966 DOI: 10.1373/Clinchem.2012.201467 |
0.744 |
|
| 2013 |
Bergamaschi MM, Barnes A, Queiroz RH, Hurd YL, Huestis MA. Impact of enzymatic and alkaline hydrolysis on CBD concentration in urine. Analytical and Bioanalytical Chemistry. 405: 4679-89. PMID 23494274 DOI: 10.1007/S00216-013-6837-X |
0.369 |
|
| 2013 |
Desrosiers NA, Barnes AJ, Hartman RL, Scheidweiler KB, Kolbrich-Spargo EA, Gorelick DA, Goodwin RS, Huestis MA. Oral fluid and plasma 3,4-methylenedioxymethamphetamine (MDMA) and metabolite correlation after controlled oral MDMA administration. Analytical and Bioanalytical Chemistry. 405: 4067-76. PMID 23471370 DOI: 10.1007/S00216-013-6848-7 |
0.363 |
|
| 2013 |
Wohlfarth A, Scheidweiler KB, Chen X, Liu HF, Huestis MA. Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search. Analytical Chemistry. 85: 3730-8. PMID 23458260 DOI: 10.1021/Ac3037365 |
0.315 |
|
| 2013 |
Bergamaschi MM, Karschner EL, Goodwin RS, Scheidweiler KB, Hirvonen J, Queiroz RH, Huestis MA. Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers' blood on per se drugged driving laws. Clinical Chemistry. 59: 519-26. PMID 23449702 DOI: 10.1373/Clinchem.2012.195503 |
0.361 |
|
| 2013 |
Bosker WM, Karschner EL, Lee D, Goodwin RS, Hirvonen J, Innis RB, Theunissen EL, Kuypers KP, Huestis MA, Ramaekers JG. Psychomotor function in chronic daily Cannabis smokers during sustained abstinence. Plos One. 8: e53127. PMID 23301031 DOI: 10.1371/Journal.Pone.0053127 |
0.536 |
|
| 2013 |
Himes SK, Scheidweiler KB, Tassiopoulos K, Kacanek D, Hazra R, Rich K, Huestis MA. Development and validation of the first liquid chromatography-tandem mass spectrometry assay for simultaneous quantification of multiple antiretrovirals in meconium. Analytical Chemistry. 85: 1896-904. PMID 23256731 DOI: 10.1021/Ac303188J |
0.318 |
|
| 2013 |
Huestis MA, Cone EJ, Pirnay SO, Umbricht A, Preston KL. Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humans Drug and Alcohol Dependence. 131: 258-262. PMID 23246635 DOI: 10.1016/J.Drugalcdep.2012.11.014 |
0.338 |
|
| 2013 |
Lee D, Karschner EL, Milman G, Barnes AJ, Goodwin RS, Huestis MA. Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration? Drug and Alcohol Dependence. 130: 68-76. PMID 23146820 DOI: 10.1016/J.Drugalcdep.2012.10.011 |
0.584 |
|
| 2013 |
Gorelick DA, Goodwin RS, Schwilke E, Schwope DM, Darwin WD, Kelly DL, McMahon RP, Liu F, Ortemann-Renon C, Bonnet D, Huestis MA. Tolerance to effects of high-dose oral δ9-tetrahydrocannabinol and plasma cannabinoid concentrations in male daily cannabis smokers. Journal of Analytical Toxicology. 37: 11-6. PMID 23074216 DOI: 10.1093/Jat/Bks081 |
0.741 |
|
| 2013 |
Vandrey R, Stitzer ML, Mintzer MZ, Huestis MA, Murray JA, Lee D. The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. Drug and Alcohol Dependence. 128: 64-70. PMID 22921474 DOI: 10.1016/J.Drugalcdep.2012.08.001 |
0.575 |
|
| 2013 |
Lee D, Schroeder JR, Karschner EL, Goodwin RS, Hirvonen J, Gorelick DA, Huestis MA. Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment: Cannabis Withdrawal in a Closed Environment American Journal On Addictions. 23: 234-242. DOI: 10.1111/J.1521-0391.2013.12088.X |
0.521 |
|
| 2012 |
Desrosiers NA, Lee D, Schwope DM, Milman G, Barnes AJ, Gorelick DA, Huestis MA. On-site test for cannabinoids in oral fluid. Clinical Chemistry. 58: 1418-25. PMID 22912396 DOI: 10.1373/Clinchem.2012.189001 |
0.783 |
|
| 2012 |
Scheidweiler KB, Desrosiers NA, Huestis MA. Simultaneous quantification of free and glucuronidated cannabinoids in human urine by liquid chromatography tandem mass spectrometry. Clinica Chimica Acta; International Journal of Clinical Chemistry. 413: 1839-47. PMID 22771478 DOI: 10.1016/J.Cca.2012.06.034 |
0.416 |
|
| 2012 |
Ropero-Miller JD, Huestis MA, Stout PR. Cocaine analytes in human hair: evaluation of concentration ratios in different cocaine sources, drug-user populations and surface-contaminated specimens. Journal of Analytical Toxicology. 36: 390-8. PMID 22593566 DOI: 10.1093/Jat/Bks050 |
0.368 |
|
| 2012 |
Schwope DM, Bosker WM, Ramaekers JG, Gorelick DA, Huestis MA. Psychomotor performance, subjective and physiological effects and whole blood Δ⁹-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis. Journal of Analytical Toxicology. 36: 405-12. PMID 22589524 DOI: 10.1093/Jat/Bks044 |
0.753 |
|
| 2012 |
Polettini A, Cone EJ, Gorelick DA, Huestis MA. Incorporation of methamphetamine and amphetamine in human hair following controlled oral methamphetamine administration. Analytica Chimica Acta. 726: 35-43. PMID 22541011 DOI: 10.1016/J.Aca.2012.01.042 |
0.371 |
|
| 2012 |
Lee D, Milman G, Schwope DM, Barnes AJ, Gorelick DA, Huestis MA. Cannabinoid stability in authentic oral fluid after controlled cannabis smoking. Clinical Chemistry. 58: 1101-9. PMID 22532594 DOI: 10.1373/Clinchem.2012.184929 |
0.777 |
|
| 2012 |
Himes SK, Goodwin RS, Rock CM, Jones HE, Johnson RE, Wilkins DG, Huestis MA. Methadone and metabolites in hair of methadone-assisted pregnant women and their infants Therapeutic Drug Monitoring. 34: 337-344. PMID 22495425 DOI: 10.1097/Ftd.0B013E3182512B26 |
0.323 |
|
| 2012 |
Karschner EL, Schwope DM, Schwilke EW, Goodwin RS, Kelly DL, Gorelick DA, Huestis MA. Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC. Drug and Alcohol Dependence. 125: 313-9. PMID 22464363 DOI: 10.1016/J.Drugalcdep.2012.03.005 |
0.744 |
|
| 2012 |
Scheidweiler KB, Shakleya DM, Huestis MA. Simultaneous quantification of nicotine, cotinine, trans-3'-hydroxycotinine, norcotinine and mecamylamine in human urine by liquid chromatography-tandem mass spectrometry. Clinica Chimica Acta; International Journal of Clinical Chemistry. 413: 978-84. PMID 22394455 DOI: 10.1016/J.Cca.2012.02.017 |
0.307 |
|
| 2012 |
Milman G, Schwope DM, Gorelick DA, Huestis MA. Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis. Clinica Chimica Acta; International Journal of Clinical Chemistry. 413: 765-70. PMID 22285315 DOI: 10.1016/J.Cca.2012.01.011 |
0.755 |
|
| 2012 |
Lee D, Schwope DM, Milman G, Barnes AJ, Gorelick DA, Huestis MA. Cannabinoid disposition in oral fluid after controlled smoked cannabis. Clinical Chemistry. 58: 748-56. PMID 22273566 DOI: 10.1373/Clinchem.2011.177881 |
0.783 |
|
| 2012 |
Rose EJ, Ross TJ, Salmeron BJ, Lee M, Shakleya DM, Huestis M, Stein EA. Chronic exposure to nicotine is associated with reduced reward-related activity in the striatum but not the midbrain. Biological Psychiatry. 71: 206-13. PMID 22032832 DOI: 10.1016/J.Biopsych.2011.09.013 |
0.314 |
|
| 2012 |
Schwaninger AE, Meyer MR, Barnes AJ, Kolbrich-Spargo EA, Gorelick DA, Goodwin RS, Huestis MA, Maurer HH. Stereoselective urinary MDMA (ecstasy) and metabolites excretion kinetics following controlled MDMA administration to humans. Biochemical Pharmacology. 83: 131-8. PMID 21983032 DOI: 10.1016/J.Bcp.2011.09.023 |
0.344 |
|
| 2012 |
Goodwin RS, Baumann MH, Gorelick DA, Schwilke E, Schwope DM, Darwin WD, Kelly DL, Schroeder JR, Ortemann-Renon C, Bonnet D, Huestis MA. CB1 - cannabinoid receptor antagonist effects on cortisol in cannabis-dependent men. The American Journal of Drug and Alcohol Abuse. 38: 114-9. PMID 21797816 DOI: 10.3109/00952990.2011.600398 |
0.703 |
|
| 2012 |
Donovan DM, Bigelow GE, Brigham GS, Carroll KM, Cohen AJ, Gardin JG, Hamilton JA, Huestis MA, Hughes JR, Lindblad R, Marlatt GA, Preston KL, Selzer JA, Somoza EC, Wakim PG, et al. Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction (Abingdon, England). 107: 694-708. PMID 21781202 DOI: 10.1111/J.1360-0443.2011.03473.X |
0.301 |
|
| 2011 |
Schwaninger AE, Meyer MR, Barnes AJ, Kolbrich-Spargo EA, Gorelick DA, Goodwin RS, Huestis MA, Maurer HH. Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration. Clinical Chemistry. 57: 1748-56. PMID 21980168 DOI: 10.1373/Clinchem.2011.172254 |
0.347 |
|
| 2011 |
Milman G, Schwope DM, Schwilke EW, Darwin WD, Kelly DL, Goodwin RS, Gorelick DA, Huestis MA. Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration. Clinical Chemistry. 57: 1597-606. PMID 21875944 DOI: 10.1373/Clinchem.2011.169490 |
0.77 |
|
| 2011 |
Scheidweiler KB, Ladenheim B, Barnes AJ, Cadet JL, Huestis MA. (±)-3,4-methylenedioxymethamphetamine and metabolite disposition in plasma and striatum of wild-type and multidrug resistance protein 1a knock-out mice. Journal of Analytical Toxicology. 35: 470-80. PMID 21871156 DOI: 10.1093/Anatox/35.7.470 |
0.324 |
|
| 2011 |
Gorelick DA, Goodwin RS, Schwilke E, Schwope DM, Darwin WD, Kelly DL, McMahon RP, Liu F, Ortemann-Renon C, Bonnet D, Huestis MA. Antagonist-elicited cannabis withdrawal in humans. Journal of Clinical Psychopharmacology. 31: 603-12. PMID 21869692 DOI: 10.1097/Jcp.0B013E31822Befc1 |
0.753 |
|
| 2011 |
Barnes AJ, Scheidweiler KB, Kolbrich-Spargo EA, Gorelick DA, Goodwin RS, Huestis MA. MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration. Therapeutic Drug Monitoring. 33: 602-8. PMID 21860342 DOI: 10.1097/Ftd.0B013E3182281975 |
0.382 |
|
| 2011 |
Scheidweiler KB, Marrone GF, Shakleya DM, Singleton EG, Heishman SJ, Huestis MA. Oral fluid nicotine markers to assess smoking status and recency of use. Therapeutic Drug Monitoring. 33: 609-18. PMID 21860341 DOI: 10.1097/Ftd.0B013E318228Ba39 |
0.344 |
|
| 2011 |
Concheiro M, Jones HE, Johnson RE, Choo R, Huestis MA. Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women Therapeutic Drug Monitoring. 33: 619-626. PMID 21860340 DOI: 10.1097/Ftd.0B013E318228Bb2A |
0.384 |
|
| 2011 |
Schwope DM, Karschner EL, Gorelick DA, Huestis MA. Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration. Clinical Chemistry. 57: 1406-14. PMID 21836075 DOI: 10.1373/Clinchem.2011.171777 |
0.771 |
|
| 2011 |
Holland MG, Schwope DM, Stoppacher R, Gillen SB, Huestis MA. Postmortem redistribution of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH). Forensic Science International. 212: 247-51. PMID 21764230 DOI: 10.1016/J.Forsciint.2011.06.028 |
0.746 |
|
| 2011 |
de Castro A, Jones HE, Johnson RE, Gray TR, Shakleya DM, Huestis MA. Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes. Therapeutic Drug Monitoring. 33: 443-52. PMID 21743375 DOI: 10.1097/Ftd.0B013E31822724F0 |
0.337 |
|
| 2011 |
Schwope DM, Scheidweiler KB, Huestis MA. Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography-tandem mass spectrometry. Analytical and Bioanalytical Chemistry. 401: 1273-83. PMID 21727996 DOI: 10.1007/S00216-011-5197-7 |
0.743 |
|
| 2011 |
Lee D, Milman G, Barnes AJ, Goodwin RS, Hirvonen J, Huestis MA. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence. Clinical Chemistry. 57: 1127-36. PMID 21677094 DOI: 10.1373/Clinchem.2011.164822 |
0.605 |
|
| 2011 |
Schwaninger AE, Meyer MR, Huestis MA, Maurer HH. Development and validation of LC-HRMS and GC-NICI-MS methods for stereoselective determination of MDMA and its phase i and II metabolites in human urine Journal of Mass Spectrometry. 46: 603-614. PMID 21656610 DOI: 10.1002/Jms.1929 |
0.342 |
|
| 2011 |
Milman G, Barnes AJ, Schwope DM, Schwilke EW, Goodwin RS, Kelly DL, Gorelick DA, Huestis MA. Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration. Analytical and Bioanalytical Chemistry. 401: 599-607. PMID 21637933 DOI: 10.1007/S00216-011-5066-4 |
0.79 |
|
| 2011 |
Marrone GF, Shakleya DM, Scheidweiler KB, Singleton EG, Huestis MA, Heishman SJ. Relative performance of common biochemical indicators in detecting cigarette smoking. Addiction (Abingdon, England). 106: 1325-34. PMID 21438939 DOI: 10.1111/J.1360-0443.2011.03441.X |
0.311 |
|
| 2011 |
Huestis MA, Verstraete A, Kwong TC, Morland J, Vincent MJ, de la Torre R. Oral fluid testing: promises and pitfalls. Clinical Chemistry. 57: 805-10. PMID 21350039 DOI: 10.1373/Clinchem.2010.152124 |
0.378 |
|
| 2011 |
Karschner EL, Darwin WD, McMahon RP, Liu F, Wright S, Goodwin RS, Huestis MA. Subjective and physiological effects after controlled Sativex and oral THC administration. Clinical Pharmacology and Therapeutics. 89: 400-7. PMID 21289620 DOI: 10.1038/Clpt.2010.318 |
0.382 |
|
| 2011 |
de Castro A, Jones HE, Johnson RE, Gray TR, Shakleya DM, Huestis MA. Maternal methadone dose, placental methadone concentrations, and neonatal outcomes. Clinical Chemistry. 57: 449-58. PMID 21245372 DOI: 10.1373/Clinchem.2010.154864 |
0.372 |
|
| 2011 |
Concheiro M, Shakleya DM, Huestis MA. Simultaneous analysis of buprenorphine, methadone, cocaine, opiates and nicotine metabolites in sweat by liquid chromatography tandem mass spectrometry Analytical and Bioanalytical Chemistry. 400: 69-78. PMID 21125263 DOI: 10.1007/S00216-010-4392-2 |
0.376 |
|
| 2011 |
Karschner EL, Darwin WD, Goodwin RS, Wright S, Huestis MA. Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration. Clinical Chemistry. 57: 66-75. PMID 21078841 DOI: 10.1373/Clinchem.2010.152439 |
0.325 |
|
| 2011 |
Gray TR, Dams R, Choo RE, Jones HE, Huestis MA. Methadone disposition in oral fluid during pharmacotherapy for opioid-dependence Forensic Science International. 206: 98-102. PMID 20667673 DOI: 10.1016/J.Forsciint.2010.06.031 |
0.42 |
|
| 2011 |
Delaney-Black V, Chiodo LM, Hannigan JH, Greenwald MK, Janisse J, Patterson G, Huestis MA, Partridge RT, Ager J, Sokol RJ. Prenatal and postnatal cocaine exposure predict teen cocaine use. Neurotoxicology and Teratology. 33: 110-9. PMID 20609384 DOI: 10.1016/J.Ntt.2010.06.011 |
0.306 |
|
| 2010 |
Concheiro M, Jones HE, Johnson RE, Choo R, Shakleya DM, Huestis MA. Umbilical cord monitoring of in utero drug exposure to buprenorphine and correlation with maternal dose and neonatal outcomes Journal of Analytical Toxicology. 34: 498-505. PMID 21819795 DOI: 10.1093/Jat/34.8.498 |
0.363 |
|
| 2010 |
Delaney-Black V, Chiodo LM, Hannigan JH, Greenwald MK, Janisse J, Patterson G, Huestis MA, Ager J, Sokol RJ. Just say "I don't": lack of concordance between teen report and biological measures of drug use. Pediatrics. 126: 887-93. PMID 20974792 DOI: 10.1542/Peds.2009-3059 |
0.307 |
|
| 2010 |
Gray TR, Choo RE, Concheiro M, Williams E, Elko A, Jansson LM, Jones HE, Huestis MA. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome. Addiction (Abingdon, England). 105: 2151-9. PMID 20854338 DOI: 10.1111/J.1360-0443.2010.03097.X |
0.327 |
|
| 2010 |
Scheidweiler KB, Spargo EA, Kelly TL, Cone EJ, Barnes AJ, Huestis MA. Pharmacokinetics of cocaine and metabolites in human oral fluid and correlation with plasma concentrations after controlled administration. Therapeutic Drug Monitoring. 32: 628-37. PMID 20814350 DOI: 10.1097/Ftd.0B013E3181F2B729 |
0.411 |
|
| 2010 |
Concheiro M, Gray TR, Shakleya DM, Huestis MA. High-throughput simultaneous analysis of buprenorphine, methadone, cocaine, opiates, nicotine, and metabolites in oral fluid by liquid chromatography tandem mass spectrometry Analytical and Bioanalytical Chemistry. 398: 915-924. PMID 20652688 DOI: 10.1007/S00216-010-3903-5 |
0.341 |
|
| 2010 |
Gray TR, Eiden RD, Leonard KE, Connors GJ, Shisler S, Huestis MA. Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth. Clinical Chemistry. 56: 1442-50. PMID 20628142 DOI: 10.1373/Clinchem.2010.147876 |
0.309 |
|
| 2010 |
Barnes AJ, Brunet BR, Choo RE, Mura P, Johnson RE, Jones HE, Huestis MA. Excretion of methadone in sweat of pregnant women throughout gestation after controlled methadone administration. Therapeutic Drug Monitoring. 32: 497-503. PMID 20592651 DOI: 10.1097/Ftd.0B013E3181E44293 |
0.37 |
|
| 2010 |
Milman G, Barnes AJ, Schwope DM, Schwilke EW, Darwin WD, Goodwin RS, Kelly DL, Gorelick DA, Huestis MA. Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration. Clinical Chemistry. 56: 1261-9. PMID 20530732 DOI: 10.1373/Clinchem.2009.141853 |
0.754 |
|
| 2010 |
Gray TR, Barnes AJ, Huestis MA. Effect of hydrolysis on identifying prenatal cannabis exposure Analytical and Bioanalytical Chemistry. 397: 2335-2347. PMID 20517601 DOI: 10.1007/S00216-010-3772-Y |
0.318 |
|
| 2010 |
Gray TR, Eiden RD, Leonard KE, Connors G, Shisler S, Huestis MA. Nicotine and metabolites in meconium as evidence of maternal cigarette smoking during pregnancy and predictors of neonatal growth deficits. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 12: 658-64. PMID 20427459 DOI: 10.1093/Ntr/Ntq068 |
0.324 |
|
| 2010 |
Schwope DM, Milman G, Huestis MA. Validation of an enzyme immunoassay for detection and semiquantification of cannabinoids in oral fluid. Clinical Chemistry. 56: 1007-14. PMID 20360126 DOI: 10.1373/Clinchem.2009.141754 |
0.753 |
|
| 2010 |
Karschner EL, Barnes AJ, Lowe RH, Scheidweiler KB, Huestis MA. Validation of a two-dimensional gas chromatography mass spectrometry method for the simultaneous quantification of cannabidiol, Delta(9)-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in plasma. Analytical and Bioanalytical Chemistry. 397: 603-11. PMID 20306180 DOI: 10.1007/S00216-010-3599-6 |
0.388 |
|
| 2010 |
Smith ML, Shimomura E, Paul BD, Cone EJ, Darwin WD, Huestis MA. Urinary excretion of ecgonine and five other cocaine metabolites following controlled oral, intravenous, intranasal, and smoked administration of cocaine. Journal of Analytical Toxicology. 34: 57-63. PMID 20223096 DOI: 10.1093/Jat/34.2.57 |
0.388 |
|
| 2010 |
Concheiro M, Jones HE, Johnson RE, Choo R, Shakleya DM, Huestis MA. Maternal buprenorphine dose, placenta buprenorphine, and metabolite concentrations and neonatal outcomes Therapeutic Drug Monitoring. 32: 206-215. PMID 20216119 DOI: 10.1097/Ftd.0B013E3181D0Bd68 |
0.366 |
|
| 2010 |
Shakleya DM, Dams R, Choo RE, Hendree J, Huestis MA. Simultaneous liquid chromatography-mass spectrometry quantification of urinary opiates, cocaine, and metabolites in opiate-dependent pregnantwomen in methadone-maintenance treatment Journal of Analytical Toxicology. 34: 17-25. PMID 20109298 DOI: 10.1093/Jat/34.1.17 |
0.348 |
|
| 2010 |
Milman G, Barnes AJ, Lowe RH, Huestis MA. Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry Journal of Chromatography A. 1217: 1513-1521. PMID 20083251 DOI: 10.1016/J.Chroma.2009.12.053 |
0.4 |
|
| 2010 |
Brunet BR, Barnes AJ, Choo RE, Mura P, Jones HE, Huestis MA. Monitoring pregnant women's illicit opiate and cocaine use with sweat testing. Therapeutic Drug Monitoring. 32: 40-9. PMID 19927046 DOI: 10.1097/Ftd.0B013E3181C13Aaf |
0.362 |
|
| 2009 |
Westin AA, Huestis MA, Aarstad K, Spigset O. Urinary excretion of 11-nor-9-carboxy-Δ9- tetrahydrocannabinol in a pregnant woman following heavy, chronic cannabis use Journal of Analytical Toxicology. 33: 610-614. PMID 20040136 DOI: 10.1093/Jat/33.9.610 |
0.413 |
|
| 2009 |
Concheiro M, Jones H, Johnson RE, Shakleya DM, Huestis MA. Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 878: 13-20. PMID 19945361 DOI: 10.1016/J.Jchromb.2009.11.005 |
0.345 |
|
| 2009 |
Gray TR, LaGasse LL, Smith LM, Derauf C, Grant P, Shah R, Arria AM, Della Grotta SA, Strauss A, Haning WF, Lester BM, Huestis MA. Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) study. Therapeutic Drug Monitoring. 31: 769-75. PMID 19935364 DOI: 10.1097/Ftd.0B013E3181Bb438E |
0.363 |
|
| 2009 |
Karschner EL, Schwilke EW, Lowe RH, Darwin WD, Herning RI, Cadet JL, Huestis MA. Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers. Journal of Analytical Toxicology. 33: 469-77. PMID 19874654 DOI: 10.1093/Jat/33.8.469 |
0.369 |
|
| 2009 |
Abraham TT, Barnes AJ, Lowe RH, Kolbrich Spargo EA, Milman G, Pirnay SO, Gorelick DA, Goodwin RS, Huestis MA. Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans. Journal of Analytical Toxicology. 33: 439-46. PMID 19874650 DOI: 10.1093/Jat/33.8.439 |
0.422 |
|
| 2009 |
Shakleya DM, Huestis MA. Optimization and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of nicotine, cotinine, trans-3′-hydroxycotinine and norcotinine in human oral fluid Analytical and Bioanalytical Chemistry. 395: 2349-2357. PMID 19838828 DOI: 10.1007/S00216-009-3157-2 |
0.372 |
|
| 2009 |
Schwilke EW, Schwope DM, Karschner EL, Lowe RH, Darwin WD, Kelly DL, Goodwin RS, Gorelick DA, Huestis MA. Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC. Clinical Chemistry. 55: 2180-9. PMID 19833841 DOI: 10.1373/Clinchem.2008.122119 |
0.754 |
|
| 2009 |
Huestis MA. A new ultraperformance - Tandem mass spectrometry oral fluid assay for 29 illicit drugs and medications Clinical Chemistry. 55: 2079-2081. PMID 19833833 DOI: 10.1373/Clinchem.2009.134551 |
0.417 |
|
| 2009 |
Shakleya DM, Huestis MA. Simultaneous and sensitive measurement of nicotine, cotinine, trans-3′-hydroxycotinine and norcotinine in human plasma by liquid chromatography-tandem mass spectrometry Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 877: 3537-3542. PMID 19748838 DOI: 10.1016/J.Jchromb.2009.08.033 |
0.372 |
|
| 2009 |
Baumann MH, Zolkowska D, Kim I, Scheidweiler KB, Rothman RB, Huestis MA. Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the rat. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 37: 2163-70. PMID 19679675 DOI: 10.1124/Dmd.109.028506 |
0.366 |
|
| 2009 |
De Castro A, Concheiro M, Shakleya DM, Huestis MA. Simultaneous quantification of methadone, cocaine, opiates, and metabolites in human placenta by liquid chromatography-mass spectrometry Journal of Analytical Toxicology. 33: 243-252. PMID 19671243 DOI: 10.1093/Jat/33.5.243 |
0.418 |
|
| 2009 |
de Castro A, Concheiro M, Shakleya DM, Huestis MA. Development and validation of a liquid chromatography mass spectrometry assay for the simultaneous quantification of methadone, cocaine, opiates and metabolites in human umbilical cord Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 877: 3065-3071. PMID 19656745 DOI: 10.1016/J.Jchromb.2009.07.028 |
0.346 |
|
| 2009 |
Lowe RH, Abraham TT, Darwin WD, Herning R, Cadet JL, Huestis MA. Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure. Drug and Alcohol Dependence. 105: 24-32. PMID 19631478 DOI: 10.1016/J.Drugalcdep.2009.05.027 |
0.343 |
|
| 2009 |
Smith ML, Barnes AJ, Huestis MA. Identifying new cannabis use with urine creatinine-normalized THCCOOH concentrations and time intervals between specimen collections. Journal of Analytical Toxicology. 33: 185-9. PMID 19470219 DOI: 10.1093/Jat/33.4.185 |
0.38 |
|
| 2009 |
Mueller M, Kolbrich EA, Peters FT, Maurer HH, McCann UD, Huestis MA, Ricaurte GA. Direct comparison of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") disposition and metabolism in squirrel monkeys and humans. Therapeutic Drug Monitoring. 31: 367-73. PMID 19417716 DOI: 10.1097/Ftd.0B013E3181A4F6C2 |
0.785 |
|
| 2009 |
Concheiro M, Shakleya DM, Huestis MA. Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphine-glucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry Forensic Science International. 188: 144-151. PMID 19406593 DOI: 10.1016/J.Forsciint.2009.04.005 |
0.319 |
|
| 2009 |
Kacinko SL, Jones HE, Johnson RE, Choo RE, Concheiro-Guisan M, Huestis MA. Urinary excretion of buprenorphine, norbuprenorphine, buprenorphine-glucuronide, and norbuprenorphine-glucuronide in pregnant women receiving buprenorphine maintenance treatment. Clinical Chemistry. 55: 1177-87. PMID 19325013 DOI: 10.1373/Clinchem.2008.113712 |
0.701 |
|
| 2009 |
Schwilke EW, Karschner EL, Lowe RH, Gordon AM, Cadet JL, Herning RI, Huestis MA. Intra- and intersubject whole blood/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusing. Clinical Chemistry. 55: 1188-95. PMID 19264857 DOI: 10.1373/Clinchem.2008.114405 |
0.343 |
|
| 2009 |
Concheiro-Guisan M, Shakleya DM, Huestis MA. Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry Analytical and Bioanalytical Chemistry. 394: 513-522. PMID 19247639 DOI: 10.1007/S00216-009-2706-Z |
0.341 |
|
| 2009 |
Gray TR, Shakleya DM, Huestis MA. A liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 20 drugs of abuse and metabolites in human meconium Analytical and Bioanalytical Chemistry. 393: 1977-1990. PMID 19241063 DOI: 10.1007/S00216-009-2680-5 |
0.383 |
|
| 2009 |
Shakleya DM, Huestis MA. Simultaneous quantification of nicotine, opioids, cocaine, and metabolites in human fetal postmortem brain by liquid chromatography tandem mass spectrometry Analytical and Bioanalytical Chemistry. 393: 1957-1965. PMID 19229524 DOI: 10.1007/S00216-009-2661-8 |
0.351 |
|
| 2009 |
Mueller M, Kolbrich-Spargo EA, Peters FT, Huestis MA, Ricaurte GA, Maurer HH. Hydrolysis of 3,4-methylenedioxymethamphetamine (MDMA) metabolite conjugates in human, squirrel monkey, and rat plasma. Analytical and Bioanalytical Chemistry. 393: 1607-17. PMID 19183967 DOI: 10.1007/S00216-009-2607-1 |
0.308 |
|
| 2009 |
Barnes AJ, De Martinis BS, Gorelick DA, Goodwin RS, Kolbrich EA, Huestis MA. Disposition of MDMA and metabolites in human sweat following controlled MDMA administration. Clinical Chemistry. 55: 454-62. PMID 19168553 DOI: 10.1373/Clinchem.2008.117093 |
0.794 |
|
| 2009 |
Mueller M, Peters FT, Huestis MA, Ricaurte GA, Maurer HH. Simultaneous liquid chromatographic-electrospray ionization mass spectrometric quantification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its metabolites 3,4-dihydroxymethamphetamine, 4-hydroxy-3-methoxymethamphetamine and 3,4-methylenedioxyamphetamine in squirrel monkey and human plasma after acidic conjugate cleavage. Forensic Science International. 184: 64-8. PMID 19131196 DOI: 10.1016/J.Forsciint.2008.12.002 |
0.383 |
|
| 2009 |
Gray TR, Kelly T, LaGasse LL, Smith LM, Derauf C, Haning W, Grant P, Shah R, Arria A, Strauss A, Lester BM, Huestis MA. Novel biomarkers of prenatal methamphetamine exposure in human meconium. Therapeutic Drug Monitoring. 31: 70-5. PMID 19125148 DOI: 10.1097/Ftd.0B013E318195D7Cb |
0.392 |
|
| 2008 |
Scheidweiler KB, Barnes AJ, Huestis MA. A validated gas chromatographic-electron impact ionization mass spectrometric method for methamphetamine, methylenedioxymethamphetamine (MDMA), and metabolites in mouse plasma and brain. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 876: 266-76. PMID 19026602 DOI: 10.1016/J.Jchromb.2008.11.001 |
0.331 |
|
| 2008 |
Goodwin RS, Darwin WD, Chiang CN, Shih M, Li SH, Huestis MA. Urinary elimination of 11-nor-9-carboxy-delta9-tetrahydrocannnabinol in cannabis users during continuously monitored abstinence. Journal of Analytical Toxicology. 32: 562-9. PMID 19007504 DOI: 10.1093/Jat/32.8.562 |
0.371 |
|
| 2008 |
Walsh JM, Verstraete AG, Huestis MA, Mørland J. Guidelines for research on drugged driving Addiction. 103: 1258-1268. PMID 18855814 DOI: 10.1111/J.1360-0443.2008.02277.X |
0.309 |
|
| 2008 |
Kanneganti P, Huestis MA, Kolbrich EA, Goodwin R, Ziegelstein RC, Gorelick DA. Signal-averaged electrocardiogram in physically healthy, chronic 3,4-methylenedioxymethamphetamine (MDMA) users. The American Journal of Drug and Alcohol Abuse. 34: 712-20. PMID 18855243 DOI: 10.1080/00952990802308254 |
0.752 |
|
| 2008 |
Gray TR, Magri R, Shakleya DM, Huestis MA. Meconium nicotine and metabolites by liquid chromatography-tandem mass spectrometry: Differentiation of passive and nonexposure and correlation with neonatal outcome measures Clinical Chemistry. 54: 2018-2027. PMID 18845770 DOI: 10.1373/Clinchem.2008.109173 |
0.348 |
|
| 2008 |
Kacinko SL, Concheiro-Guisan M, Shakleya DM, Huestis MA. Development and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of buprenorphine, norbuprenorphine, and metabolites in human urine. Analytical and Bioanalytical Chemistry. 392: 903-11. PMID 18758763 DOI: 10.1007/S00216-008-2326-Z |
0.745 |
|
| 2008 |
Kacinko SL, Jones HE, Johnson RE, Choo RE, Huestis MA. Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes. Clinical Pharmacology and Therapeutics. 84: 604-12. PMID 18701886 DOI: 10.1038/Clpt.2008.156 |
0.755 |
|
| 2008 |
Kolbrich EA, Goodwin RS, Gorelick DA, Hayes RJ, Stein EA, Huestis MA. Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration. Journal of Clinical Psychopharmacology. 28: 432-40. PMID 18626271 DOI: 10.1097/Jcp.0B013E31817Ef470 |
0.788 |
|
| 2008 |
Brunet BR, Barnes AJ, Scheidweiler KB, Mura P, Huestis MA. Development and validation of a solid-phase extraction gas chromatography-mass spectrometry method for the simultaneous quantification of methadone, heroin, cocaine and metabolites in sweat. Analytical and Bioanalytical Chemistry. 392: 115-27. PMID 18607576 DOI: 10.1007/S00216-008-2228-0 |
0.381 |
|
| 2008 |
Kolbrich EA, Goodwin RS, Gorelick DA, Hayes RJ, Stein EA, Huestis MA. Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults. Therapeutic Drug Monitoring. 30: 320-32. PMID 18520604 DOI: 10.1097/Ftd.0B013E3181684Fa0 |
0.797 |
|
| 2008 |
Kelly T, Gray TR, Huestis MA. Development and validation of a liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry method for simultaneous analysis of 10 amphetamine-, methamphetamine- and 3,4-methylenedioxymethamphetamine-related (MDMA) analytes in human meconium Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 867: 194-204. PMID 18424195 DOI: 10.1016/J.Jchromb.2008.03.029 |
0.327 |
|
| 2008 |
Gray TR, Shakleya DM, Huestis MA. Quantification of nicotine, cotinine, trans-3′-hydroxycotinine, nornicotine and norcotinine in human meconium by liquid chromatography/tandem mass spectrometry Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 863: 107-114. PMID 18243821 DOI: 10.1016/J.Jchromb.2008.01.001 |
0.358 |
|
| 2008 |
Lehrmann E, Afanador ZR, Deep-Soboslay A, Gallegos G, Darwin WD, Lowe RH, Barnes AJ, Huestis MA, Cadet JL, Herman MM, Hyde TM, Kleinman JE, Freed WJ. Postmortem diagnosis and toxicological validation of illicit substance use. Addiction Biology. 13: 105-17. PMID 18201295 DOI: 10.1111/J.1369-1600.2007.00085.X |
0.32 |
|
| 2008 |
Kolbrich EA, Lowe RH, Huestis MA. Two-dimensional gas chromatography/electron-impact mass spectrometry with cryofocusing for simultaneous quantification of MDMA, MDA, HMMA, HMA, and MDEA in human plasma. Clinical Chemistry. 54: 379-87. PMID 18089653 DOI: 10.1373/Clinchem.2007.096800 |
0.792 |
|
| 2008 |
Kacinko SL, Shakleya DM, Huestis MA. Validation and application of a method for the determination of buprenorphine, norbuprenorphine, and their glucuronide conjugates in human meconium. Analytical Chemistry. 80: 246-52. PMID 18044957 DOI: 10.1021/Ac701627Q |
0.734 |
|
| 2008 |
Barnes AJ, Smith ML, Kacinko SL, Schwilke EW, Cone EJ, Moolchan ET, Huestis MA. Excretion of methamphetamine and amphetamine in human sweat following controlled oral methamphetamine administration. Clinical Chemistry. 54: 172-80. PMID 17981924 DOI: 10.1373/Clinchem.2007.092304 |
0.755 |
|
| 2008 |
Huestis MA, Scheidweiler KB, Saito T, Fortner N, Abraham T, Gustafson RA, Smith ML. Excretion of Delta9-tetrahydrocannabinol in sweat. Forensic Science International. 174: 173-7. PMID 17481836 DOI: 10.1016/J.Forsciint.2007.04.002 |
0.426 |
|
| 2007 |
Abraham TT, Lowe RH, Pirnay SO, Darwin WD, Huestis MA. Simultaneous GC-EI-MS determination of Δ9- tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol, and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in human urine following tandem enzyme-alkaline hydrolysis Journal of Analytical Toxicology. 31: 477-485. PMID 17988462 DOI: 10.1093/Jat/31.8.477 |
0.354 |
|
| 2007 |
Huestis MA, Darwin WD, Shimomura E, Lalani SA, Trinidad DV, Jenkins AJ, Cone EJ, Jacobs AJ, Smith ML, Paul BD. Cocaine and metabolites urinary excretion after controlled smoked administration. Journal of Analytical Toxicology. 31: 462-8. PMID 17988460 DOI: 10.1093/Jat/31.8.462 |
0.394 |
|
| 2007 |
Lowe RH, Karschner EL, Schwilke EW, Barnes AJ, Huestis MA. Simultaneous quantification of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry. Journal of Chromatography. A. 1163: 318-27. PMID 17640656 DOI: 10.1016/J.Chroma.2007.06.069 |
0.35 |
|
| 2007 |
Huestis MA, Boyd SJ, Heishman SJ, Preston KL, Bonnet D, Le Fur G, Gorelick DA. Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users. Psychopharmacology. 194: 505-15. PMID 17619859 DOI: 10.1007/S00213-007-0861-5 |
0.34 |
|
| 2007 |
Shakleya DM, Jansson LM, Huestis MA. Validation of a LC-APCI-MS/MS method for quantification of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) and 2-ethyl-5-methyl-3,3-diphenylpyraline (EMDP) in infant plasma following protein precipitation Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 856: 267-272. PMID 17602899 DOI: 10.1016/J.Jchromb.2007.06.004 |
0.34 |
|
| 2007 |
Choo RE, Jansson LM, Scheidweiler K, Huestis MA. A validated liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometric method for the quantification of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), and 2-ethyl-5-methyl-3,3-diphenylpyroline (EMDP) in human breast milk Journal of Analytical Toxicology. 31: 265-269. PMID 17579970 DOI: 10.1093/Jat/31.5.265 |
0.327 |
|
| 2007 |
Jansson LM, Choo RE, Harrow C, Velez M, Schroeder JR, Lowe R, Huestis MA. Concentrations of methadone in breast milk and plasma in the immediate perinatal period. Journal of Human Lactation : Official Journal of International Lactation Consultant Association. 23: 184-90. PMID 17478871 DOI: 10.1177/0890334407300336 |
0.317 |
|
| 2007 |
Gray T, Huestis M. Bioanalytical procedures for monitoring in utero drug exposure. Analytical and Bioanalytical Chemistry. 388: 1455-65. PMID 17370066 DOI: 10.1007/S00216-007-1228-9 |
0.381 |
|
| 2007 |
De Martinis BS, Barnes AJ, Scheidweiler KB, Huestis MA. Development and validation of a disk solid phase extraction and gas chromatography-mass spectrometry method for MDMA, MDA, HMMA, HMA, MDEA, methamphetamine and amphetamine in sweat. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 852: 450-8. PMID 17369000 DOI: 10.1016/J.Jchromb.2007.02.017 |
0.33 |
|
| 2007 |
Huestis MA, Cone EJ. Methamphetamine disposition in oral fluid, plasma, and urine. Annals of the New York Academy of Sciences. 1098: 104-21. PMID 17332086 DOI: 10.1196/Annals.1384.038 |
0.418 |
|
| 2007 |
Cone EJ, Huestis MA. Interpretation of oral fluid tests for drugs of abuse. Annals of the New York Academy of Sciences. 1098: 51-103. PMID 17332074 DOI: 10.1196/Annals.1384.037 |
0.408 |
|
| 2007 |
Dams R, Choo RE, Lambert WE, Jones H, Huestis MA. Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients. Drug and Alcohol Dependence. 87: 258-67. PMID 17008030 DOI: 10.1016/J.Drugalcdep.2006.08.020 |
0.392 |
|
| 2007 |
Huestis MA, Gustafson RA, Moolchan ET, Barnes A, Bourland JA, Sweeney SA, Hayes EF, Carpenter PM, Smith ML. Cannabinoid concentrations in hair from documented cannabis users. Forensic Science International. 169: 129-36. PMID 16963215 DOI: 10.1016/J.Forsciint.2006.08.005 |
0.392 |
|
| 2006 |
Huestis MA, Smith ML. Modern analytical technologies for the detection of drug abuse and doping. Drug Discovery Today. Technologies. 3: 49-57. PMID 24980101 DOI: 10.1016/J.Ddtec.2006.03.004 |
0.351 |
|
| 2006 |
Lehrmann E, Colantuoni C, Deep-Soboslay A, Becker KG, Lowe R, Huestis MA, Hyde TM, Kleinman JE, Freed WJ. Transcriptional changes common to human cocaine, cannabis and phencyclidine abuse. Plos One. 1: e114. PMID 17205118 DOI: 10.1371/Journal.Pone.0000114 |
0.338 |
|
| 2006 |
Kolbrich EA, Barnes AJ, Gorelick DA, Boyd SJ, Cone EJ, Huestis MA. Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration. Journal of Analytical Toxicology. 30: 501-10. PMID 17132243 DOI: 10.1093/Jat/30.8.501 |
0.797 |
|
| 2006 |
Goodwin RS, Gustafson RA, Barnes A, Nebro W, Moolchan ET, Huestis MA. Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids Therapeutic Drug Monitoring. 28: 545-551. PMID 16885723 DOI: 10.1097/00007691-200608000-00010 |
0.396 |
|
| 2006 |
Huestis MA, Elsohly M, Nebro W, Barnes A, Gustafson RA, Smith ML. Estimating time of last oral ingestion of cannabis from plasma THC and THCCOOH concentrations. Therapeutic Drug Monitoring. 28: 540-4. PMID 16885722 DOI: 10.1097/00007691-200608000-00009 |
0.39 |
|
| 2006 |
Pirnay SO, Abraham TT, Huestis MA. Sensitive gas chromatography-mass spectrometry method for simultaneous measurement of MDEA, MDMA, and metabolites HMA, MDA, and HMMA in human urine Clinical Chemistry. 52: 1728-1734. PMID 16858076 DOI: 10.1373/Clinchem.2006.069054 |
0.37 |
|
| 2006 |
Schwilke EW, Barnes AJ, Kacinko SL, Cone EJ, Moolchan ET, Huestis MA. Opioid disposition in human sweat after controlled oral codeine administration. Clinical Chemistry. 52: 1539-45. PMID 16740647 DOI: 10.1373/Clinchem.2006.067983 |
0.742 |
|
| 2006 |
Kim I, Huestis MA. A validated method for the determination of nicotine, cotinine, trans-3'-hydroxycotinine, and norcotinine in human plasma using solid-phase extraction and liquid chromatography-atmospheric pressure chemical ionization-mass spectrometry. Journal of Mass Spectrometry : Jms. 41: 815-21. PMID 16705667 DOI: 10.1002/Jms.1039 |
0.369 |
|
| 2006 |
Scheidweiler KB, Huestis MA. A validated gas chromatographic-electron impact ionization mass spectrometric method for methylenedioxymethamphetamine (MDMA), methamphetamine and metabolites in oral fluid. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 835: 90-9. PMID 16580268 DOI: 10.1016/J.Jchromb.2006.03.020 |
0.404 |
|
| 2006 |
Yang W, Barnes AJ, Ripple MG, Fowler DR, Cone EJ, Moolchan ET, Chung H, Huestis MA. Simultaneous quantification of methamphetamine, cocaine, codeine, and metabolites in skin by positive chemical ionization gas chromatography-mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 833: 210-8. PMID 16500159 DOI: 10.1016/J.Jchromb.2006.02.002 |
0.352 |
|
| 2006 |
Lowe RH, Barnes AJ, Lehrmann E, Freed WJ, Kleinman JE, Hyde TM, Herman MM, Huestis MA. A validated positive chemical ionization GC/MS method for the identification and quantification of amphetamine, opiates, cocaine, and metabolites in human postmortem brain. Journal of Mass Spectrometry : Jms. 41: 175-84. PMID 16382483 DOI: 10.1002/Jms.975 |
0.368 |
|
| 2005 |
Kim I, Wtsadik A, Choo RE, Jones HE, Huestis MA. Usefulness of salivary trans-3'-hydroxycotinine concentration and trans-3'-hydroxycotinine/cotinine ratio as biomarkers of cigarette smoke in pregnant women. Journal of Analytical Toxicology. 29: 689-95. PMID 16419402 DOI: 10.1093/Jat/29.7.689 |
0.382 |
|
| 2005 |
Huestis MA, Barnes A, Smith ML. Estimating the time of last cannabis use from plasma delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol concentrations. Clinical Chemistry. 51: 2289-95. PMID 16223887 DOI: 10.1373/Clinchem.2005.056838 |
0.375 |
|
| 2005 |
Kacinko SL, Barnes AJ, Schwilke EW, Cone EJ, Moolchan ET, Huestis MA. Disposition of cocaine and its metabolites in human sweat after controlled cocaine administration. Clinical Chemistry. 51: 2085-94. PMID 16166169 DOI: 10.1373/Clinchem.2005.054338 |
0.734 |
|
| 2005 |
Paul BD, Lalani S, Bosy T, Jacobs AJ, Huestis MA. Concentration profiles of cocaine, pyrolytic methyl ecgonidine and thirteen metabolites in human blood and urine: determination by gas chromatography-mass spectrometry. Biomedical Chromatography : Bmc. 19: 677-88. PMID 15841503 DOI: 10.1002/Bmc.495 |
0.366 |
|
| 2005 |
Scheidweiler KB, Cone EJ, Moolchan ET, Huestis MA. Dose-related distribution of codeine, cocaine, and metabolites into human hair following controlled oral codeine and subcutaneous cocaine administration. The Journal of Pharmacology and Experimental Therapeutics. 313: 909-15. PMID 15743923 DOI: 10.1124/Jpet.104.082388 |
0.383 |
|
| 2005 |
Choo RE, Murphy CM, Jones HE, Huestis MA. Determination of methadone, 2-ethylidene-1,5-dimethyl-3,3- diphenylpyrrolidine, 2-ethyl-5-methyl-3,3-diphenylpyraline and methadol in meconium by liquid chromatography atmospheric pressure chemical ionization tandem mass spectrometry Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 814: 369-373. PMID 15639461 DOI: 10.1016/J.Jchromb.2004.10.068 |
0.322 |
|
| 2005 |
Kim I, Darwin WD, Huestis MA. Simultaneous determination of nicotine, cotinine, norcotinine, and trans-3'-hydroxycotinine in human oral fluid using solid phase extraction and gas chromatography-mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 814: 233-40. PMID 15639444 DOI: 10.1016/J.Jchromb.2004.10.034 |
0.385 |
|
| 2005 |
Murphy CM, Huestis MA. Liquid chromatographic/electrospray ionization tandem mass spectrometric analysis for the quantification of buprenorphine, norbuprenorphine, buprenorphine-3-β-D-glucuronide and norbuprenorphine-3-β-D-glucuronide in human plasma Journal of Mass Spectrometry. 40: 70-74. PMID 15637731 DOI: 10.1002/Jms.776 |
0.316 |
|
| 2004 |
Kim I, Oyler JM, Moolchan ET, Cone EJ, Huestis MA. Urinary pharmacokinetics of methamphetamine and its metabolite, amphetamine following controlled oral administration to humans. Therapeutic Drug Monitoring. 26: 664-72. PMID 15570192 DOI: 10.1097/00007691-200412000-00013 |
0.391 |
|
| 2004 |
Huestis MA, Cone EJ. Relationship of Δ9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis Journal of Analytical Toxicology. 28: 394-399. PMID 15516285 |
0.317 |
|
| 2004 |
Umbricht A, Huestis MA, Cone EJ, Preston KL. Effects of high-dose intravenous buprenorphine in experienced opioid abusers Journal of Clinical Psychopharmacology. 24: 479-487. PMID 15349002 DOI: 10.1097/01.Jcp.0000138766.15858.C6 |
0.356 |
|
| 2004 |
Scheidweiler KB, Huestis MA. Simultaneous quantification of opiates, cocaine, and metabolites in hair by LC-APCI-MS/MS. Analytical Chemistry. 76: 4358-63. PMID 15283573 DOI: 10.1021/Ac049555T |
0.337 |
|
| 2004 |
Gustafson RA, Kim I, Stout PR, Klette KL, George MP, Moolchan ET, Levine B, Huestis MA. Urinary pharmacokinetics of 11-nor-9-carboxy-delta9-tetrahydrocannabinol after controlled oral delta9-tetrahydrocannabinol administration. Journal of Analytical Toxicology. 28: 160-7. PMID 15107145 DOI: 10.1093/Jat/28.3.160 |
0.419 |
|
| 2004 |
Kacinko SL, Barnes AJ, Kim I, Moolchan ET, Wilson L, Cooper GA, Reid C, Baldwin D, Hand CW, Huestis MA. Performance characteristics of the Cozart RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration. Forensic Science International. 141: 41-8. PMID 15066713 DOI: 10.1016/J.Forsciint.2003.12.003 |
0.756 |
|
| 2003 |
Gustafson RA, Moolchan ET, Barnes A, Levine B, Huestis MA. Validated method for the simultaneous determination of Δ 9-tetrahydrocannabinol (THC), 11-hydroxy-THC and 11-nor-9-carboxy- THC in human plasma using solid phase extraction and gas chromatography-mass spectrometry with positive chemical ionization Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 798: 145-154. PMID 14630369 DOI: 10.1016/J.Jchromb.2003.09.022 |
0.375 |
|
| 2003 |
Kolbrich EA, Kim I, Barnes AJ, Moolchan ET, Wilson L, Cooper GA, Reid C, Baldwin D, Hand CW, Huestis MA. Cozart RapiScan Oral Fluid Drug Testing System: an evaluation of sensitivity, specificity, and efficiency for cocaine detection compared with ELISA and GC-MS following controlled cocaine administration. Journal of Analytical Toxicology. 27: 407-11. PMID 14606993 DOI: 10.1093/Jat/27.7.407 |
0.792 |
|
| 2003 |
Barnes AJ, Kim I, Schepers R, Moolchan ET, Wilson L, Cooper G, Reid C, Hand C, Huestis MA. Sensitivity, specificity, and efficiency in detecting opiates in oral fluid with the Cozart Opiate Microplate EIA and GC-MS following controlled codeine administration. Journal of Analytical Toxicology. 27: 402-7. PMID 14606992 DOI: 10.1093/Jat/27.7.402 |
0.389 |
|
| 2003 |
Cone EJ, Sampson-Cone AH, Darwin WD, Huestis MA, Oyler JM. Urine testing for cocaine abuse: Metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results Journal of Analytical Toxicology. 27: 386-401. PMID 14606991 DOI: 10.1093/Jat/27.7.386 |
0.388 |
|
| 2003 |
Preston KL, Epstein DH, Davoudzadeh D, Huestis MA. Methadone and metabolite urine concentrations in patients maintained on methadone Journal of Analytical Toxicology. 27: 332-341. PMID 14516485 DOI: 10.1093/Jat/27.6.332 |
0.388 |
|
| 2003 |
Kim I, Barnes AJ, Schepers R, Moolchan ET, Wilson L, Cooper G, Reid C, Hand C, Huestis MA. Sensitivity and specificity of the Cozart microplate EIA cocaine oral fluid at proposed screening and confirmation cutoffs. Clinical Chemistry. 49: 1498-503. PMID 12928231 DOI: 10.1373/49.9.1498 |
0.393 |
|
| 2003 |
Dams R, Murphy CM, Lambert WE, Huestis MA. Urine drug testing for opioids, cocaine, and metabolites by direct injection liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry : Rcm. 17: 1665-70. PMID 12845594 DOI: 10.1002/Rcm.1098 |
0.394 |
|
| 2003 |
Gustafson RA, Levine B, Stout PR, Klette KL, George MP, Moolchan ET, Huestis MA. Urinary cannabinoid detection times after controlled oral administration of delta9-tetrahydrocannabinol to humans. Clinical Chemistry. 49: 1114-24. PMID 12816908 DOI: 10.1373/49.7.1114 |
0.394 |
|
| 2003 |
Dams R, Murphy CM, Choo RE, Lambert WE, De Leenheer AP, Huestis MA. LC-atmospheric pressure chemical ionization-MS/ MS analysis of multiple illicit drugs, methadone, and their metabolites in oral fluid following protein precipitation. Analytical Chemistry. 75: 798-804. PMID 12622369 DOI: 10.1021/Ac026111T |
0.41 |
|
| 2002 |
Preston KL, Epstein DH, Cone EJ, Wtsadik AT, Huestis MA, Moolchan ET. Urinary elimination of cocaine metabolites in chronic cocaine users during cessation Journal of Analytical Toxicology. 26: 393-400. PMID 12422991 DOI: 10.1093/Jat/26.7.393 |
0.332 |
|
| 2002 |
Oyler JM, Cone EJ, Joseph RE, Moolchan ET, Huestis MA. Duration of detectable methamphetamine and amphetamine excretion in urine after controlled oral administration of methamphetamine to humans. Clinical Chemistry. 48: 1703-14. PMID 12324487 DOI: 10.1093/Clinchem/48.10.1703 |
0.387 |
|
| 2002 |
LeBeau MA, Christenson RH, Levine B, Darwin WD, Huestis MA. Intra- and interindividual variations in urinary concentrations of endogenous gamma-hydroxybutyrate. Journal of Analytical Toxicology. 26: 340-6. PMID 12220015 DOI: 10.1093/Jat/26.6.340 |
0.331 |
|
| 2002 |
Huestis MA, Choo RE. Drug abuse's smallest victims: In utero drug exposure Forensic Science International. 128: 20-30. PMID 12208017 DOI: 10.1016/S0379-0738(02)00160-3 |
0.36 |
|
| 2002 |
Lyons TP, Okano CK, Kuhnle JA, Bruins MR, Darwin WD, Moolchan ET, Huestis MA. A comparison of Roche Kinetic Interaction of Microparticles in Solution (KIMS) assay for cannabinoids and GC-MS analysis for 11-nor-9-carboxy-delta9-tetrahydrocannabinol. Journal of Analytical Toxicology. 25: 559-64. PMID 11599600 DOI: 10.1093/Jat/25.7.559 |
0.358 |
|
| 2002 |
Kim I, Barnes AJ, Oyler JM, Schepers R, Joseph RE, Cone EJ, Lafko D, Moolchan ET, Huestis MA. Plasma and Oral Fluid Pharmacokinetics and Pharmacodynamics after Oral Codeine Administration Clinical Chemistry. 48: 1486-1496. DOI: 10.1093/Clinchem/48.9.1486 |
0.406 |
|
| 2001 |
Huang W, Moody DE, Andrenyak DM, Smith EK, Foltz RL, Huestis MA, Newton JF. Simultaneous determination of delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol in human plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry. Journal of Analytical Toxicology. 25: 531-7. PMID 11599596 DOI: 10.1093/Jat/25.7.531 |
0.386 |
|
| 2001 |
Spanbauer AC, Casseday S, Davoudzadeh D, Preston KL, Huestis MA. Detection of opiate use in a methadone maintenance treatment population with the CEDIA® 6-acetylmorphine and CEDIA DAU opiate assays Journal of Analytical Toxicology. 25: 515-519. PMID 11599593 DOI: 10.1093/Jat/25.7.515 |
0.395 |
|
| 2001 |
Polettini A, Huestis MA. Simultaneous determination of buprenorphine, norbuprenorphine, and buprenorphine-glucuronide in plasma by liquid chromatography-tandem mass spectrometry Journal of Chromatography B: Biomedical Sciences and Applications. 754: 447-459. PMID 11339288 DOI: 10.1016/S0378-4347(01)00029-9 |
0.346 |
|
| 2000 |
Oyler JM, Cone EJ, Joseph RE, Huestis MA. Identification of hydrocodone in human urine following controlled codeine administration. Journal of Analytical Toxicology. 24: 530-5. PMID 11043655 DOI: 10.1093/Jat/24.7.530 |
0.432 |
|
| 2000 |
Huestis MA, Cone EJ, Wong CJ, Umbricht A, Preston KL. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing Journal of Analytical Toxicology. 24: 509-521. PMID 11043653 DOI: 10.1093/Jat/24.7.509 |
0.412 |
|
| 2000 |
Moolchan ET, Cone EJ, Wstadik A, Huestis MA, Preston KL. Cocaine and metabolite elimination patterns in chronic cocaine users during cessation: Plasma and saliva analysis Journal of Analytical Toxicology. 24: 458-466. PMID 11043647 DOI: 10.1093/Jat/24.7.458 |
0.33 |
|
| 1999 |
Huestis MA, Oyler JM, Cone EJ, Wstadik AT, Schoendorfer D, Joseph RE. Sweat testing for cocaine, codeine and metabolites by gas chromatography-mass spectrometry. Journal of Chromatography. B, Biomedical Sciences and Applications. 733: 247-64. PMID 10572984 DOI: 10.1016/S0378-4347(99)00246-7 |
0.406 |
|
| 1999 |
Nath N, Eldefrawi M, Wright J, Darwin D, Huestis M. A rapid reusable fiber optic biosensor for detecting cocaine metabolites in urine. Journal of Analytical Toxicology. 23: 460-7. PMID 10517551 DOI: 10.1093/Jat/23.6.460 |
0.324 |
|
| 1999 |
Preston KL, Huestis MA, Wong CJ, Umbricht A, Goldberger BA, Cone EJ. Monitoring cocaine use in substance-abuse-treatment patients by sweat and urine testing Journal of Analytical Toxicology. 23: 313-322. PMID 10488917 DOI: 10.1093/Jat/23.5.313 |
0.349 |
|
| 1999 |
Preston KL, Huestis MA, Wong CJ, Cone EJ. Urine and sweat monitoring of illicit opiate use Clinical Pharmacology and Therapeutics. 65: 153. DOI: 10.1016/S0009-9236(99)80142-8 |
0.408 |
|
| 1998 |
Huestis MA, Cone EJ. Differentiating new marijuana use from residual drug excretion in occasional marijuana users Journal of Analytical Toxicology. 22: 445-454. PMID 9788519 DOI: 10.1093/Jat/22.6.445 |
0.412 |
|
| 1998 |
Huestis MA, Cone EJ. Urinary excretion half-life of 11-nor-9-carboxy-Δ9- tetrahydrocannabinol in humans Therapeutic Drug Monitoring. 20: 570-576. PMID 9780137 DOI: 10.1097/00007691-199810000-00021 |
0.384 |
|
| 1996 |
Wilkins D, Haughey H, Cone E, Huestis M, Foltz R, Rollins D. Quantitative analysis of THC, 11-OH-THC, and THCCOOH in human hair by negative ion chemical ionization mass spectrometry. Journal of Analytical Toxicology. 19: 483-91. PMID 8926743 DOI: 10.1093/Jat/19.6.483 |
0.359 |
|
| 1996 |
Huestis MA, Mitchell JM, Cone EJ. Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana. Journal of Analytical Toxicology. 20: 441-52. PMID 8889681 DOI: 10.1093/Jat/20.6.441 |
0.441 |
|
| 1995 |
Huestis MA, Mitchell JM, Cone EJ. Detection times of marijuana metabolites in urine by immunoassay and GC-MS. Journal of Analytical Toxicology. 19: 443-9. PMID 8926739 DOI: 10.1093/Jat/19.6.443 |
0.391 |
|
| 1994 |
Huestis MA, Mitchell JM, Cone EJ. Lowering the federally mandated cannabinoid immunoassay cutoff increases true-positive results. Clinical Chemistry. 40: 729-33. PMID 8174244 DOI: 10.1093/Clinchem/40.5.729 |
0.326 |
|
| 1993 |
Cone EJ, Huestis MA, Mitchell JM. Do consecutive urine catches differ in marijuana metabolite concentration? Journal of Analytical Toxicology. 17: 186-7. PMID 8336494 DOI: 10.1093/Jat/17.3.186 |
0.329 |
|
| 1993 |
Huestis MA, Cone EJ. Relating blood concentrations of tetrahydrocannabinol and metabolites to pharmacologic effects and time of marijuana usage Therapeutic Drug Monitoring. 15: 527-532. PMID 8122288 DOI: 10.1097/00007691-199312000-00013 |
0.369 |
|
| 1990 |
Heishman SJ, Huestis MA, Henningfield JE, Cone EJ. Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures. Pharmacology, Biochemistry, and Behavior. 37: 561-5. PMID 1965045 DOI: 10.1016/0091-3057(90)90028-G |
0.34 |
|
| Show low-probability matches. |